Literature DB >> 20186491

Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Corey E Tabit1, William B Chung, Naomi M Hamburg, Joseph A Vita.   

Abstract

Cardiovascular disease is a major complication of diabetes mellitus, and improved strategies for prevention and treatment are needed. Endothelial dysfunction contributes to the pathogenesis and clinical expression of atherosclerosis in diabetes mellitus. This article reviews the evidence linking endothelial dysfunction to human diabetes mellitus and experimental studies that investigated the responsible mechanisms. We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186491      PMCID: PMC2882637          DOI: 10.1007/s11154-010-9134-4

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  225 in total

Review 1.  Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid.

Authors:  A R Smith; T M Hagen
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

2.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.

Authors:  P L Ludmer; A P Selwyn; T L Shook; R R Wayne; G H Mudge; R W Alexander; P Ganz
Journal:  N Engl J Med       Date:  1986-10-23       Impact factor: 91.245

3.  Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance.

Authors:  R Rubio; R M Berne
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

4.  Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.

Authors:  G O'Driscoll; D Green; A Maiorana; K Stanton; F Colreavy; R Taylor
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate.

Authors:  T M Hagen; R T Ingersoll; J Lykkesfeldt; J Liu; C M Wehr; V Vinarsky; J C Bartholomew; A B Ames
Journal:  FASEB J       Date:  1999-02       Impact factor: 5.191

6.  Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus.

Authors:  Joshua A Beckman; Allison B Goldfine; Mary Beth Gordon; Leslie A Garrett; John F Keaney; Mark A Creager
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-24       Impact factor: 4.733

7.  Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species.

Authors:  Ming-Hui Zou; Stacy S Kirkpatrick; Bradley J Davis; John S Nelson; Walter G Wiles; Uwe Schlattner; Dietbert Neumann; Michael Brownlee; Michael B Freeman; Mitch H Goldman
Journal:  J Biol Chem       Date:  2004-07-19       Impact factor: 5.157

8.  Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile.

Authors:  Umberto Campia; Gail Sullivan; Melissa B Bryant; Myron A Waclawiw; Michael J Quon; Julio A Panza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-28       Impact factor: 4.733

9.  G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.

Authors:  Massimo Federici; Assunta Pandolfi; Elena Anna De Filippis; Giuliana Pellegrini; Rossella Menghini; Davide Lauro; Marina Cardellini; Mario Romano; Giorgio Sesti; Renato Lauro; Agostino Consoli
Journal:  Circulation       Date:  2004-01-05       Impact factor: 29.690

10.  In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.

Authors:  Frank Pistrosch; Jens Passauer; Sabine Fischer; Katja Fuecker; Markolf Hanefeld; Peter Gross
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

View more
  184 in total

Review 1.  [Vascular ultrasonography].

Authors:  H Stiegler
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

2.  Diabetic retinopathy and endothelial dysfunction in patients with type 2 diabetes mellitus.

Authors:  Jae-Seung Yun; Seung-Hyun Ko; Ji-Hoon Kim; Keon-Woong Moon; Kun-Woong Moon; Yong-Moon Park; Ki-Dong Yoo; Yu-Bae Ahn
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

3.  Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.

Authors:  Clothilde Roche; Marie Besnier; Roméo Cassel; Najah Harouki; David Coquerel; Dominique Guerrot; Lionel Nicol; Emmanuelle Loizon; Isabelle Remy-Jouet; Christophe Morisseau; Paul Mulder; Antoine Ouvrard-Pascaud; Anne-Marie Madec; Vincent Richard; Jeremy Bellien
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

4.  Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy.

Authors:  Michael E Widlansky; Venkata K Puppala; Tisha M Suboc; Mobin Malik; Amberly Branum; Kara Signorelli; Jingli Wang; Rong Ying; Michael J Tanner; Sudhi Tyagi
Journal:  Vasc Med       Date:  2017-02-01       Impact factor: 3.239

Review 5.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

6.  Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction.

Authors:  Ya Guo; Shaoxun Wang; Yedan Liu; Letao Fan; George W Booz; Richard J Roman; Zongbo Chen; Fan Fan
Journal:  Geroscience       Date:  2020-03-12       Impact factor: 7.713

7.  Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans.

Authors:  Tinoy J Kizhakekuttu; Jingli Wang; Kodlipet Dharmashankar; Rong Ying; David D Gutterman; Joseph A Vita; Michael E Widlansky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-09       Impact factor: 8.311

8.  Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus.

Authors:  Mor-Li Hartman; Orian S Shirihai; Monika Holbrook; Guoquan Xu; Marsha Kocherla; Akash Shah; Jessica L Fetterman; Matthew A Kluge; Alissa A Frame; Naomi M Hamburg; Joseph A Vita
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

9.  Nitric oxide regulates vascular adaptive mitochondrial dynamics.

Authors:  Matthew W Miller; Leslie A Knaub; Luis F Olivera-Fragoso; Amy C Keller; Vivek Balasubramaniam; Peter A Watson; Jane E B Reusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

10.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.